When a new drug enters the market, it brings with it both hope and uncertainty. Clinical trials, despite their scientific rigor, are limited in scope — they can’t predict how a drug will behave in real-world conditions, across varied patient…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
